DISCLOSEDQuarterlyRenaissance TechnologiesXbiotech Inc · NASDAQ22,438 sh · $52.7KFiled 31 Mar 2026·SEC 13F·view source
DISCLOSEDStaleBlackRockXbiotech Inc · NASDAQ1,134,146 sh · $5.8MFiled 30 Jun 2024·SEC 13F·view source